A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors
Recruiting · NCT07473726 · Registry updated 2026-07-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors | Advanced/Metastatic Solid Tumors | Recruiting | Phase 1 | 2026-07-02 | NCT07473726 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Henlius Biotech | 58 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| GenesisCare St.Leonards | Saint Leonards | Australia | 1 |
| Macquarie University | North Ryde | Australia | 15 |
| Peninsula and South Eastern Haematology and Oncology Group | Frankston | Australia | 6 |
| Shanghai General Hospital | Hongkou | China | 1 |
| Shanxi Provincial Cancer Hospital | Taiyuan | China | 6 |
| Sun Yat-Sen University Cancer Center | Guangzhou | China | 1 |
| Zhujiang Hospital of Southern Medical University | Guangzhou | China | 33 |